Savvy Advisors Inc. Purchases 1,724 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Savvy Advisors Inc. grew its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 108.6% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 3,312 shares of the healthcare conglomerate’s stock after purchasing an additional 1,724 shares during the quarter. Savvy Advisors Inc.’s holdings in UnitedHealth Group were worth $1,937,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Kathleen S. Wright Associates Inc. acquired a new stake in UnitedHealth Group during the third quarter worth approximately $27,000. Global Wealth Strategies & Associates grew its position in shares of UnitedHealth Group by 152.4% during the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after buying an additional 32 shares during the period. Macroview Investment Management LLC lifted its position in shares of UnitedHealth Group by 671.4% during the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock valued at $28,000 after acquiring an additional 47 shares during the period. West Financial Advisors LLC bought a new stake in UnitedHealth Group in the third quarter valued at $32,000. Finally, Delos Wealth Advisors LLC boosted its position in shares of UnitedHealth Group by 757.1% during the 1st quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock worth $30,000 after purchasing an additional 53 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

Shares of NYSE UNH opened at $619.88 on Tuesday. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The company’s 50-day moving average is $582.63 and its 200 day moving average is $546.78. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.88. The stock has a market capitalization of $570.47 billion, a P/E ratio of 40.73, a P/E/G ratio of 1.81 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping the consensus estimate of $7.00 by $0.15. The business had revenue of $100.82 billion for the quarter, compared to the consensus estimate of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The company’s quarterly revenue was up 9.2% on a year-over-year basis. During the same period last year, the firm earned $6.56 earnings per share. On average, sell-side analysts expect that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be given a dividend of $2.10 per share. The ex-dividend date is Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.36%. UnitedHealth Group’s payout ratio is 54.72%.

Analyst Ratings Changes

Several research analysts have issued reports on the company. Cantor Fitzgerald increased their price target on UnitedHealth Group from $591.00 to $644.00 and gave the stock an “overweight” rating in a report on Wednesday, October 16th. UBS Group dropped their target price on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a report on Wednesday, October 16th. Robert W. Baird raised their target price on UnitedHealth Group from $597.00 to $640.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 17th. Stephens reduced their target price on shares of UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating for the company in a research note on Wednesday, October 16th. Finally, Wells Fargo & Company upped their price target on UnitedHealth Group from $525.00 to $630.00 and gave the company an “overweight” rating in a research report on Wednesday, July 17th. Four analysts have rated the stock with a hold rating, seventeen have given a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat.com, UnitedHealth Group has a consensus rating of “Moderate Buy” and an average target price of $615.53.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.